HHMI
INGR icon

Howard Hughes Medical Institute’s Ingredion INGR Stock Holding History

Howard Hughes Medical Institute’s Portfolio INGR Stock Details INGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-669
Closed -$46K – 208
2014
Q1 		$46K Buy
669
+308
+85% +$20.2K 0.01% 154
2013
Q4 		$25K Buy
+361
New +$24.4K ﹤0.01% 173

Other funds holding INGR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Howard Hughes Medical Institute's INGR Position: Q2 2014 in Review

Howard Hughes Medical Institute sold out of Ingredion (INGR) in Q2 2014, closing a stake of 669 shares — an estimated $46K sold.

Howard Hughes Medical Institute first reported a position in INGR in Q4 2013 and held it in 2 quarters. The position peaked at $46K in Q1 2014. 345 funds tracked by Wall St. Rank hold INGR as of Q2 2014.

  • Howard Hughes Medical Institute reported no remaining Ingredion position as of Q2 2014 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 669 Ingredion shares in Q2 2014, an estimated $46K.
  • Howard Hughes Medical Institute first reported a position in Ingredion in Q4 2013 and held it in 2 quarters.
  • Howard Hughes Medical Institute's Ingredion position peaked at $46K in Q1 2014.
  • 345 funds tracked by Wall St. Rank held Ingredion as of Q2 2014.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2014, filed 1 Aug 2014.